Pasar saham, bursa saham dinten
harga Bagikeun of 71229 pausahaan sacara real waktu.
Pasar saham, bursa saham dinten

Tanda petik stock

Stock tanda petik Online

Sajarah harga saham

dimodalan pasar saham

Dividends on biasa

Untung ti biasa dina pausahaan

laporan keuangan

Peunteun pausahaan. Dimana pikeun investasi?

Arrowhead Pharmaceuticals, Inc. cap pasar

Volume biasa dagang Arrowhead Pharmaceuticals, Inc. dinten na sajarah dimodalan Arrowhead Pharmaceuticals, Inc. ti awal dagang di biasa ARWR dina bursa saham.
nambahkeun widget
Dipasang dina widget

Arrowhead Pharmaceuticals, Inc. dimodalan

Kiwari, dimodalan pasar Arrowhead Pharmaceuticals, Inc. nyaeta 4 199 178 752 Dollar AS.
+367 170 816 $ (+9.58%)
change of dimodalan saprak kamari

Arrowhead Pharmaceuticals, Inc. dimodalan pasar dina dolar ayeuna. Arrowhead Pharmaceuticals, Inc. dimodalan ayeuna dianggap salaku jumlah tina kutipan saham Arrowhead Pharmaceuticals, Inc. koin dikaluarkeun. Arrowhead Pharmaceuticals, Inc. dimodalan pikeun dinten ayeuna dina situs wéb pikeun rujukan. Arrowhead Pharmaceuticals, Inc. cap pasar ayeuna nya $ 4 199 178 752.

Arrowhead Pharmaceuticals, Inc. volume dagang

Dinten volume dagang di biasa Arrowhead Pharmaceuticals, Inc. amounted ka 878 829 Dollar AS.
-278 938 $ (-24.09%)
change of volume dagang saprak kamari

Arrowhead Pharmaceuticals, Inc. volume padagang ayeuna nyaéta 878 829 dolar AS. Dinten ayeuna, dagang Arrowhead Pharmaceuticals, Inc. lumangsung di sababaraha pasar saham. Arrowhead Pharmaceuticals, Inc. bagan dagang aya dina situs wéb kami unggal dinten. Arrowhead Pharmaceuticals, Inc. kapitalisasi parantos ningkat dibandingkeun kamari.

Tembongkeun:
Ka

Arrowhead Pharmaceuticals, Inc. bagan cap pasar

15.46% per minggu - perobalan pasar modal Arrowhead Pharmaceuticals, Inc.. 0% per bulan - perobalan pasar modal Arrowhead Pharmaceuticals, Inc.. Arrowhead Pharmaceuticals, Inc. modifikasi kapitalisasi pikeun taun nyaéta 0%. Kapitalisasi pasar Arrowhead Pharmaceuticals, Inc. ayeuna sami sareng 4 199 178 752 dolar AS.

minggu Sasih 3 bulan taun 3 taun

Arrowhead Pharmaceuticals, Inc. sajarah dimodalan

Kaping Dimodalan
Dimodalan (dimodalan pasar) - ngarupakeun nilai pasar sadaya biasa pausahaan traded dina bursa saham. dimodalan pasar teh harga dibagikeun dikali Jumlah biasa beredar.
03/05/2023 4 199 178 752 $
02/05/2023 3 832 007 936 $
01/05/2023 3 864 500 736 $
28/04/2023 3 769 729 536 $
27/04/2023 3 797 348 864 $
26/04/2023 3 664 668 672 $
25/04/2023 3 637 050 112 $

Arrowhead Pharmaceuticals, Inc. bagan volume

minggu Sasih 3 bulan taun 3 taun

data sajarah volume Arrowhead Pharmaceuticals, Inc.

Kaping Volume (24h)
Volume biasa traded Arrowhead Pharmaceuticals, Inc. - jumlah total sakabéh transaksi jeung biasa tina ARWR, meuli jeung dijual mangsa tanggal dipilih.
03/05/2023 878 829 $
02/05/2023 1 157 767 $
01/05/2023 296 761 $
28/04/2023 191 198 $
27/04/2023 609 939 $
26/04/2023 430 082 $
25/04/2023 3 609 240 $

Arrowhead Pharmaceuticals, Inc. dimodalan di 03/05/2023 sami sareng 4 199 178 752 dolar AS. 02/05/2023 Arrowhead Pharmaceuticals, Inc. Kapitalisasi pasar sami sareng 3 832 007 936 dolar AS. 01/05/2023 Arrowhead Pharmaceuticals, Inc. permodalan berjumlah 3 864 500 736 dolar AS. Arrowhead Pharmaceuticals, Inc. dimodalan berjumlah 3 769 729 536 dolar AS di 28/04/2023.

Arrowhead Pharmaceuticals, Inc. dimodalan di 27/04/2023 berjumlah 3 797 348 864 dolar AS. Arrowhead Pharmaceuticals, Inc. dimodalan pasar nyaéta $ 3 664 668 672 at 26/04/2023. Arrowhead Pharmaceuticals, Inc. dimodalan di 25/04/2023 berjumlah 3 637 050 112 dolar AS.

Dimodalan Arrowhead Pharmaceuticals, Inc. ayeuna nangtung dina 4 199 178 752 $. dimodalan Market Arrowhead Pharmaceuticals, Inc. robah jadi +9.58% dibandingkeun jeung kamari sore. Dagang kekembangan biasa ARWR Arrowhead Pharmaceuticals, Inc. dina dinten dagang panungtungan amounted ka 878 829 $ biasa tina volume dagang Arrowhead Pharmaceuticals, Inc. robah jadi -24.0928% dibandingkeun kalawan dinten dagang saméméhna.

Nilai biasa Arrowhead Pharmaceuticals, Inc.

Keuangan Arrowhead Pharmaceuticals, Inc.